Correlation between Changes in Serum RBP4, hs-CRP, and IL-27 Levels and Rosuvastatin in the Treatment of Coronary Heart Disease

Figure 1

Comparison of changes of RBP4 level. Note: The abscissa indicated the time nodes, and the ordinate indicated the level, mg/L. The RBP4 levels of the CG before treatment, at 4 weeks, 8 weeks, and 12 weeks of treatment were (35.76 ± 10.42), (26.64 ± 8.41), (24.49 ± 6.11), and (23.06 ± 5.57). The RBP4 levels of the SG before treatment, at 4 weeks, 8 weeks, and 12 weeks of treatment were (35.34 ± 10.35), (23.55 ± 6.87), (22.26 ± 6.15), and (20.92 ± 5.72). ^∗indicates the obvious difference in the RBP4 level at 4 weeks of treatment between both groups (t = 2.170,  = 0.032).